Anti-Interleukin-1 Agents in Adult Onset Still's Disease

Por Giampietro, Cecilia, Fautrel, Bruno
Publicado em 2012

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’

Por Vastesaeger, Nathan, Fautrel, Bruno, Smolen, Josef
Publicado no Arthritis Res Ther (2015)

Mechanisms, biomarkers and targets for adult-onset Still’s disease

Por Feist, Eugen, Mitrovic, Stéphane, Fautrel, Bruno
Publicado no Nat Rev Rheumatol (2018)

Adult-Onset Still’s Disease

Por Mitrovic, Stéphane, Feist, Eugen, Fautrel, Bruno
Publicado no Periodic and Non-Periodic Fevers (2019)

Long-term return to work after a functional restoration program for chronic low-back pain patients: a prospective study

Por Poulain, Cécile, Kernéis, Solen, Rozenberg, Sylvie, Fautrel, Bruno, Bourgeois, Pierre, Foltz, Violaine
Publicado em 2010

Adult Onset Still's Disease and Autoinflammation

Por Efthimiou, Petros, Moorthy, L. Nandini, Mavragani, Clio P., Skokos, Dimitris, Fautrel, Bruno
Publicado em 2012

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort

Por Fautrel, Bruno, Granger, Benjamin, Combe, Bernard, Saraux, Alain, Guillemin, Francis, Le Loet, Xavier
Publicado em 2012

Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation stud...

Por Granger, Benjamin, Combe, Bernard, Le Loet, Xavier, Saraux, Alain, Guillemin, Francis, Fautrel, Bruno
Publicado no RMD Open (2016)

Steps in implementing a health economic evaluation

Por Guillemin, Francis, de Wit, Maarten, Fautrel, Bruno, Grimm, Sabine, Joore, Manuela, Boonen, Annelies
Publicado no RMD Open (2020)

Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?

Por de Wit, Maarten, Guillemin, Francis, Grimm, Sabine, Boonen, Annelies, Fautrel, Bruno, Joore, Manuela
Publicado no RMD Open (2020)

Cost assessment of health interventions and diseases

Por Fautrel, Bruno, Boonen, Annelies, de Wit, Maarten, Grimm, Sabine, Joore, Manuela, Guillemin, Francis
Publicado no RMD Open (2020)

Health technology assessment: a framework

Por Joore, Manuela, Grimm, Sabine, Boonen, Annelies, de Wit, Maarten, Guillemin, Francis, Fautrel, Bruno
Publicado no RMD Open (2020)

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort

Por Harvard, Stephanie, Guh, Daphne, Bansback, Nick, Richette, Pascal, Dougados, Maxime, Anis, Aslam, Fautrel, Bruno
Publicado no RMD Open (2016)

bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search

Por Verhoef, Lise M., Tweehuysen, Lieke, Hulscher, Marlies E., Fautrel, Bruno, den Broeder, Alfons A.
Publicado no Rheumatol Ther (2017)

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Por Harvard, Stephanie, Guh, Daphne, Bansback, Nick, Richette, Pascal, Saraux, Alain, Fautrel, Bruno, Anis, Aslam
Publicado no Cost Eff Resour Alloc (2017)

Dosing down with biologic therapies: a systematic review and clinicians’ perspective

Por Edwards, Christopher J, Fautrel, Bruno, Schulze-Koops, Hendrik, Huizinga, Tom W J, Kruger, Klaus
Publicado no Rheumatology (Oxford) (2018)

Dosing down with biologic therapies: a systematic review and clinicians’ perspective

Por Edwards, Christopher J, Fautrel, Bruno, Schulze-Koops, Hendrik, Huizinga, Tom W J, Kruger, Klaus
Publicado no Rheumatology (Oxford) (2017)

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

Por Lukas, Cédric, Mary, Julia, Debandt, Michel, Daïen, Claire, Morel, Jacques, Cantagrel, Alain, Fautrel, Bruno, Combe, Bernard
Publicado no Arthritis Res Ther (2019)

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Por Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimón, Bao, Min, Bernasconi, Corrado, Pethö-Schramm, Attila
Publicado no Rheumatology (Oxford) (2018)

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Por Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimón, Bao, Min, Bernasconi, Corrado, Pethö-Schramm, Attila
Publicado no Rheumatology (Oxford) (2018)